Who are SARUM?


Sarum Partners is a team of strategic management consultants to the oncology sector.

The Partners bring together 4 distinct skill sets, oncology entrepreneurs who have successfully built and sold over 12 oncology companies between them; commercial scientists who have discovered and invented technologies in the Cancer arena; practising clinical oncologists who are on the ‘coal face’ and financial expertise in biotechnology and valuation techniques.

Sarum Partners and related parties own 49% of MTL. The team comprises of the founder, Jonathan Beaton-Hird who is a current Director of MTL.

Sarum Partners was the entity which has supported MTL from inception and wishes to maximise the development potential of all MTL products and are keen to resist early exists from the product development phases unless shareholder value can be maximised.